Healthcare Services

Whole Genome and Exome Sequencing Market Outlook Showing Growth to $7.63 Billion by 2030

April 28, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Whole Genome And Exome Sequencing Market Over The 2026–2030 Period?

The whole genome and exome sequencing market has experienced rapid expansion in its size over recent years. Projections indicate it will expand from $2.52 billion in 2025 to $3.14 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 24.8%. This historical expansion is linked to improvements in next-generation sequencing technologies, the rising application of genomics in cancer studies, the spread of academic genomics projects, reductions in sequencing expenditures, and the development of precision medicine efforts.

The whole genome and exome sequencing market size is projected to experience substantial growth over the coming years. This market is predicted to reach $7.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.8%. This expansion during the projection period stems from factors such as the increasing implementation of large-scale genomics initiatives, the growing incorporation of AI in genomic analysis, wider adoption of clinical genomics, escalating investments in sequencing infrastructure, and the rising need for tailored treatment approaches. Key trends anticipated within this forecast period encompass the greater uptake of comprehensive genome sequencing, the increasing application of sequencing in oncology diagnostics, a surging demand for integrated WGS and WES workflows, the broadening scope of population genomics research, and an intensified focus on high-throughput sequencing platforms.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp

Which Strong Drivers Are Impacting The Whole Genome And Exome Sequencing Market Growth?

The increasing demand for personalized medicine is projected to fuel the expansion of the whole genome and exome sequencing market moving forward. Personalized medicine represents a medical treatment methodology that customizes healthcare decisions and interventions for each patient’s individual characteristics, considering elements such as genetics, environment, and lifestyle. Whole genome and exome sequencing supports personalized medicine by delivering an extensive analysis of an individual’s genetic composition, thus enabling healthcare decisions and interventions to be specifically tailored according to their distinct genetic, environmental, and lifestyle factors. For instance, in February 2024, as per the Personalized Medicine Coalition (PMC), a US-based organization advocating for the understanding and adoption of personalized medicine, 26 personalized medicines obtained FDA approval, comprising 20 new molecular entities (NMEs) and 6 gene-/cell-based therapies, which constituted approximately 38% of all newly approved therapeutic NMEs. Consequently, the rising need for personalized medicine is driving the growth of the whole genome and exome sequencing market.

Which Segment Classifications Are Used In The Whole Genome And Exome Sequencing Market Segment Analysis?

The whole genome and exome sequencing market covered in this report is segmented –

1) By Product Type: Kits, Instruments

2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)

3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications

4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits

2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems

Which Trends Are Contributing To Changes In The Whole Genome And Exome Sequencing Market?

Leading companies within the whole genome and exome sequencing markets are concentrating more on developing sophisticated technological solutions, like ultra-fast NGS (next-generation sequencing) analysis, to achieve a competitive advantage. This ultra-fast NGS analysis is a technological advancement designed to process next-generation sequencing (NGS) data with remarkable speed, substantially cutting down the duration needed for genomic data interpretation. As an example, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, unveiled an ultra-fast NGS analysis platform. The platform boasts features like processing an entire genome in 25 minutes for just $1 in cloud computing expenses, thereby fostering efficiency, affordability, and scalability. Such technological innovation profoundly improves the speed and accessibility of genomic data analysis, consequently holding significant weight in the whole genome and exome sequencing market by allowing for swift decision-making and broader embrace of personalized medicine.

Which Firms Are Contributing To The Whole Genome And Exome Sequencing Market Ecosystem?

Major companies operating in the whole genome and exome sequencing market are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V, BGI Genomics, Novogene Co., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., GENEWIZ Inc., 10x Genomics Inc., MGI Tech Co. Ltd., Clear Labs Inc., Macrogen Inc., PierianDx Inc., Invitae Corporation, Fulgent Genetics Inc., SOPHiA GENETICS SA, Azenta US Inc., Gene by Gene Ltd.

Get The Full Whole Genome And Exome Sequencing Market Report:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Which Region Has The Greatest Market Share In The Whole Genome And Exome Sequencing Market?

North America was the largest region in the whole genome and exome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Whole Genome And Exome Sequencing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2026, By The Business Research Company

Whole Exome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Next Generation Sequencing Market

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

Dna Sequencing Market Report

https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795